JP2023051961A5 - - Google Patents

Download PDF

Info

Publication number
JP2023051961A5
JP2023051961A5 JP2022200267A JP2022200267A JP2023051961A5 JP 2023051961 A5 JP2023051961 A5 JP 2023051961A5 JP 2022200267 A JP2022200267 A JP 2022200267A JP 2022200267 A JP2022200267 A JP 2022200267A JP 2023051961 A5 JP2023051961 A5 JP 2023051961A5
Authority
JP
Japan
Prior art keywords
alkyl chain
disease
compound according
compound
mitochondrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022200267A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023051961A (ja
JP7689690B2 (ja
Filing date
Publication date
Priority claimed from JP2019530099A external-priority patent/JP2020503280A/ja
Application filed filed Critical
Publication of JP2023051961A publication Critical patent/JP2023051961A/ja
Publication of JP2023051961A5 publication Critical patent/JP2023051961A5/ja
Application granted granted Critical
Publication of JP7689690B2 publication Critical patent/JP7689690B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022200267A 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用 Active JP7689690B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PT109818 2016-12-29
PT10981816 2016-12-29
JP2019530099A JP2020503280A (ja) 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用
PCT/IB2017/058508 WO2018122789A1 (en) 2016-12-29 2017-12-29 Hydroxybenzoic acid derivatives, methods and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019530099A Division JP2020503280A (ja) 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用

Publications (3)

Publication Number Publication Date
JP2023051961A JP2023051961A (ja) 2023-04-11
JP2023051961A5 true JP2023051961A5 (cg-RX-API-DMAC7.html) 2023-04-18
JP7689690B2 JP7689690B2 (ja) 2025-06-09

Family

ID=61074472

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019530099A Pending JP2020503280A (ja) 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用
JP2022200267A Active JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019530099A Pending JP2020503280A (ja) 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用

Country Status (8)

Country Link
US (1) US11078222B2 (cg-RX-API-DMAC7.html)
EP (1) EP3562830B1 (cg-RX-API-DMAC7.html)
JP (2) JP2020503280A (cg-RX-API-DMAC7.html)
KR (1) KR102750630B1 (cg-RX-API-DMAC7.html)
CN (1) CN110114365B (cg-RX-API-DMAC7.html)
BR (1) BR112019011303B1 (cg-RX-API-DMAC7.html)
CA (1) CA3048966A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018122789A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3925961A4 (en) * 2019-10-30 2022-05-11 Fusion Biotechnology Co., Ltd. Mitochondria-targeting compound and composition comprising same for treating or preventing aging-related diseases
WO2023053059A1 (en) * 2021-09-30 2023-04-06 Universidade Do Porto Antifouling compound, method and uses thereof
WO2023220365A1 (en) * 2022-05-13 2023-11-16 Virginia Tech Intellectual Properties, Inc. Mitochondrial antioxidant treatment for cask-linked neurodevelopmental disorders
US20260097092A1 (en) * 2022-09-21 2026-04-09 Ulsan National Institute Of Science And Technology Pharmaceutical composition containing mitochondria-targeting compound as active ingredient for treating macular degeneration
KR102894216B1 (ko) * 2022-12-15 2025-12-18 울산과학기술원 Trap-1 억제제
CN116210697B (zh) * 2023-03-02 2024-05-14 西北农林科技大学 反式肉桂酸在提高苹果树腐烂病抗性中的应用
KR20250126454A (ko) * 2024-02-16 2025-08-25 울산과학기술원 암 세포의 티오에스테라제 및 활성산소종에 의해 자가 조립 중합되는 단량체 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2860266C (en) 2009-04-27 2017-10-31 Iowa State University Research Foundation, Inc. Neuroprotective compounds and their use
GB201320636D0 (en) * 2013-11-22 2014-01-08 Medical Res Council Compounds
MX2018010829A (es) * 2016-03-08 2019-02-07 Univ Michigan Regents Inductores de molécula pequeña de especies de oxígeno reactivo e inhibidores de la actividad mitocondrial.
US10913757B2 (en) * 2016-10-14 2021-02-09 Universidade Do Porto Hydroxycinnamic derivatives, methods and uses thereof

Similar Documents

Publication Publication Date Title
US12329739B2 (en) Isoflavonoid compounds and methods for the treatment of cancer
JP2020503280A5 (cg-RX-API-DMAC7.html)
JP7689690B2 (ja) ヒドロキシ安息香酸誘導体、その方法および使用
SG188610A1 (en) Methods and compositions for treating lung cancer
JP6824906B2 (ja) 併用療法
US9850195B2 (en) Aspirin derivatives and uses thereof
US20230233519A1 (en) Combination therapies
US20260000629A1 (en) Ferroptosis inhibitor
AU2008229617A1 (en) Method for inducing autophagy
CN110198929A (zh) 用于治疗真菌感染的组合物和方法
JP6484448B2 (ja) 新規gem−ジヒドロペルオキシド化合物
US20120238511A1 (en) 2-deoxy-d-glucose formulations for prevention or treatment of neurodegenerative diseases
JP2021533115A (ja) 神経疾患またはミトコンドリア疾患の処置のための化合物
JP2019535795A (ja) 口腔感染症の処置のための組成物及び方法
US12447137B2 (en) Composition for prevention, amelioration, or treatment of cancer
US20090298868A1 (en) Quinoline compounds as melanogenesis modifiers and uses thereof
Abdou et al. Metallo-organic Copper (II) Complex in Nano Size as a New Smart Therapeutic Bomb for Hepatocellular Carcinoma
AU2702097A (en) Antioxidant compounds
EP3708563B1 (en) Selenopsammaplin a and derivative thereof, preparation method therefor, and composition for preventing and treating cancer, containing same as active ingredients
KR102741641B1 (ko) 설포라판을 유효성분으로 포함하는 피부 질환의 예방, 개선 또는 치료용 조성물
US20140275280A1 (en) Therapeutic uses of geranylgeranyl acetone and derivatives thereof
KR102466024B1 (ko) 암의 예방, 개선 또는 치료용 조성물
JP2005507869A (ja) 特殊構造を持つ新規抗癌化合物の一群
JP4490536B2 (ja) 脳血管障害に基づく疾患の予防又は治療薬
EP1720849A1 (fr) Derives de pyranone utiles pour le traitement du cancer